{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T16:45:32Z","timestamp":1793810732499,"version":"4.6.1"},"reference-count":116,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.critrevonc.2026.105223","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:19:44Z","timestamp":1771460384000},"page":"105223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Blood-based biomarkers for breast cancer screening and early diagnosis: Diagnostic performance and challenges for clinical implementation"],"prefix":"10.1016","volume":"221","author":[{"given":"Marcela","family":"Esquivel-Vel\u00e1zquez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"P\u00e9rez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galileo","family":"Escobedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda A.","family":"M\u00e9ndez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Fonseca-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenin","family":"Snowball-del-Pilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"C\u00e9rbulo-V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nallely","family":"Bueno-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7620","key":"10.1016\/j.critrevonc.2026.105223_bib1","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nature19949","article-title":"Mass-spectrometric exploration of proteome structure and function","volume":"537","author":"Aebersold","year":"2016","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105223_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0250642","article-title":"Small extracellular vesicle-encapsulated miR-181b-5p, miR-222-3p and let-7a-5p: Next generation plasma biopsy-based diagnostic biomarkers for inflammatory breast cancer","volume":"16","author":"Ahmed","year":"2021","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105223_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0283001","article-title":"Analytical validation of a multi-cancer early detection test with cancer signal origin using a cell-free DNA\u2013based targeted methylation assay","volume":"18","author":"Alexander","year":"2023","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105223_bib4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41523-024-00626-6","article-title":"Circulating tumor DNA validity and potential uses in metastatic breast cancer","volume":"10","author":"Amato","year":"2024","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.critrevonc.2026.105223_bib5","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1158\/0008-5472.CAN-11-3266","article-title":"Concordant Release of Glycolysis Proteins into the Plasma Preceding a Diagnosis of ER+ Breast Cancer","volume":"72","author":"Amon","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2026.105223_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1137519","article-title":"Clinical diagnostic biomarker \u201ccirculating tumor cells\u201d in breast cancer - a meta-analysis","volume":"13","author":"Bai","year":"2023","journal-title":"Front Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105223_bib7","first-page":"201","article-title":"The changing face of circulating tumor DNA (ctDNA) profiling: Factors that shape the landscape of methodologies, technologies, and commercialization","volume":"35","author":"Bronkhorst","year":"2023","journal-title":"Med. Genet."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105223_bib8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/10408363.2019.1700902","article-title":"Early detection of cancer using circulating tumor DNA: biological, physiological and analytical considerations","volume":"57","author":"Bronkhorst","year":"2020","journal-title":"Crit. Rev. Clin. Lab Sci."},{"key":"10.1016\/j.critrevonc.2026.105223_bib9","doi-asserted-by":"crossref","first-page":"102","DOI":"10.37349\/etat.2023.00125","article-title":"Diagnostic value of liquid biopsy in the era of precision medicine: 10 years of clinical evidence in cancer","author":"Caputo","year":"2023","journal-title":"Explor Target Antitumor Ther. 4(1"},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105223_bib10","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/annonc\/mdz173","article-title":"Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"30","author":"Cardoso","year":"2019","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105223_bib11","doi-asserted-by":"crossref","first-page":"168","DOI":"10.7326\/0003-4819-138-3-200302040-00008","article-title":"Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography","volume":"138","author":"Carney","year":"2003","journal-title":"Ann. Intern Med"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105223_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-38886-0","article-title":"Plasma microRNA ratios associated with breast cancer detection in a nested case\u2013control study from a mammography screening cohort","volume":"13","author":"Chiorino","year":"2023","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105223_bib13","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s13277-014-2700-8","article-title":"Diagnostic value of circulating microRNAs as biomarkers for breast cancer: a meta-analysis study","volume":"36","author":"Cui","year":"2015","journal-title":"Tumor Biol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105223_bib14","article-title":"Extracellular vesicles as a promising source of lipid biomarkers for breast cancer detection in blood plasma","volume":"13","author":"Dorado","year":"2024","journal-title":"J. Extra Vesicles"},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105223_bib15","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3390\/cells8070727","article-title":"Overview of Extracellular Vesicles, Their Origin, Composition, Purpose, and Methods for Exosome Isolation and Analysis","volume":"8","author":"Doyle","year":"2019","journal-title":"Cells"},{"issue":"23-24","key":"10.1016\/j.critrevonc.2026.105223_bib16","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.cca.2010.08.039","article-title":"CA 15-3: uses and limitations as a biomarker for breast cancer","volume":"411","author":"Duffy","year":"2010","journal-title":"Clin. Chim. Acta"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105223_bib17","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000217898","article-title":"The diagnostic value of CA 27-29, CA 15-3, mucin-like carcinoma antigen, carcinoembryonic antigen and CA 19-9 in breast and gastrointestinal malignancies","volume":"15","author":"Frenette","year":"1994","journal-title":"Tumor Biol."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105223_bib18","doi-asserted-by":"crossref","first-page":"8270","DOI":"10.3390\/ijms24098270","article-title":"MicroRNA dysregulation in early breast cancer diagnosis: a systematic review and meta-analysis","volume":"24","author":"Garrido-Palacios","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105223_bib19","doi-asserted-by":"crossref","first-page":"942","DOI":"10.15252\/msb.20156297","article-title":"Revisiting biomarker discovery by plasma proteomics","volume":"13","author":"Geyer","year":"2017","journal-title":"Mol Syst Biol"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105223_bib20","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1186\/s12967-024-05843-y","article-title":"Comprehensive analysis of the metabolomics and transcriptomics uncovers the dysregulated network and potential biomarkers of Triple Negative Breast Cancer","volume":"22","author":"Gong","year":"2024","journal-title":"J. Transl. Med."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105223_bib21","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3390\/bios15040257","article-title":"Innovative methodologies for the early detection of breast cancer: a review categorized by target biological samples","volume":"15","author":"Grasso","year":"2025","journal-title":"Biosensors"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105223_bib22","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.3390\/medicina61061112","article-title":"Interpretable machine learning for serum-based metabolomics in breast cancer diagnostics: insights from multi-objective feature selection-driven LightGBM-SHAP models","volume":"61","author":"Guldogan","year":"2025","journal-title":"Medicina"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105223_bib23","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1038\/s41598-017-01924-9","article-title":"Serum Metabolomic Profiles for Breast Cancer Diagnosis, Grading and Staging by Gas Chromatography-Mass Spectrometry","volume":"7","author":"Hadi","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105223_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.134","article-title":"Whole-genome circulating tumor DNA methylation landscape reveals sensitive biomarkers of breast cancer","volume":"3","author":"Hai","year":"2022","journal-title":"MedComm"},{"key":"10.1016\/j.critrevonc.2026.105223_bib25","article-title":"Serum amino acids quantification by plasmonic colloidosome-coupled MALDI-TOF MS for triple-negative breast cancer diagnosis","volume":"17","author":"Han","year":"2022","journal-title":"Mater. Today Bio"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105223_bib26","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2217\/bmm-2017-0305","article-title":"Exosomal microRNA: a novel biomarker for breast cancer","volume":"12","author":"He","year":"2018","journal-title":"Biomark. Med"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105223_bib27","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/1354750X.2023.2246700","article-title":"Exploring the potential of humanin as a biomarker for early breast cancer detection: a study of serum levels and diagnostic performance","volume":"28","author":"Hek\u0131m","year":"2023","journal-title":"Biomarkers"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105223_bib28","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1158\/1078-0432.CCR-18-0843","article-title":"A noninvasive blood-based combinatorial proteomic biomarker assay to detect breast cancer in women over age 50 with BI-RADS 3, 4, or 5 assessment","volume":"25","author":"Henderson","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105223_bib29","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.7150\/jca.57019","article-title":"A panel of tumor-associated autoantibodies for the detection of early-stage breast cancer","volume":"12","author":"Hong","year":"2021","journal-title":"J. Cancer"},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105223_bib30","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1016\/j.asjsur.2023.05.115","article-title":"Exosomal microRNAs as novel diagnostic biomarkers in breast cancer: a systematic evaluation and meta-analysis","volume":"46","author":"Hong","year":"2023","journal-title":"Asian J. Surg."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105223_bib31","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1158\/2767-9764.CRC-23-0505","article-title":"Exosomal thomsen\u2013friedenreich glycoantigen: a new liquid biopsy biomarker for lung and breast cancer diagnoses","volume":"4","author":"Hsu","year":"2024","journal-title":"Cancer Res. Commun."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105223_bib32","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.3390\/ijms11114175","article-title":"Proteomic serum biomarkers and their potential application in cancer screening programs","volume":"11","author":"Huijbers","year":"2010","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2026.105223_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1103146","article-title":"Circulating tumor cells in peripheral blood as a diagnostic biomarker of breast cancer: a meta-analysis","volume":"13","author":"Jin","year":"2023","journal-title":"Front Oncol."},{"issue":"23","key":"10.1016\/j.critrevonc.2026.105223_bib34","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.3390\/cancers16234052","article-title":"Carcinoembryonic antigen expression in human tumors: a tissue microarray study on 13,725 tumors","volume":"16","author":"Jansen","year":"2024","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105223_bib35","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s00432-010-0974-9","article-title":"Identification of vitronectin as a novel serum marker for early breast cancer detection using a new proteomic approach","volume":"137","author":"Kadowaki","year":"2011","journal-title":"J. Cancer Res Clin. Oncol."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105223_bib36","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1373\/clinchem.2005.050708","article-title":"Analytical and preanalytical biases in serum proteomic pattern analysis for breast cancer diagnosis","volume":"51","author":"Karsan","year":"2005","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105223_bib37","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s13643-022-02088-y","article-title":"Can serum autoantibodies be a potential early detection biomarker for breast cancer in women? A diagnostic test accuracy review and meta-analysis","volume":"11","author":"Kathrikolly","year":"2022","journal-title":"Syst. Rev."},{"issue":"16","key":"10.1016\/j.critrevonc.2026.105223_bib38","doi-asserted-by":"crossref","first-page":"5378","DOI":"10.3390\/s24165378","article-title":"Targeted FT-NIR and SERS detection of breast cancer HER-II biomarkers in blood serum using PCB-based plasmonic active nanostructured thin film label-free immunosensor immobilized with directional GNU-conjugated antibody","volume":"24","author":"Khosroshahi","year":"2024","journal-title":"Sensors"},{"issue":"17","key":"10.1016\/j.critrevonc.2026.105223_bib39","doi-asserted-by":"crossref","first-page":"6587","DOI":"10.7150\/thno.99245","article-title":"Tumor-derived EV miRNA signatures surpass total EV miRNA in supplementing mammography for precision breast cancer diagnosis","volume":"14","author":"Kim","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.critrevonc.2026.105223_bib40","first-page":"94","article-title":"The impact of hemolysis on cell-free microRNA biomarkers","volume":"4","author":"Kirschner","year":"2013","journal-title":"Front Genet"},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105223_bib41","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.annonc.2021.05.806","article-title":"Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set","volume":"32","author":"Klein","year":"2021","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105223_bib42","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.hoc.2024.04.004","article-title":"Biomarkers in cancer screening","volume":"38","author":"Kohaar","year":"2024","journal-title":"Hematol. Oncol. Clin. North Am."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105223_bib43","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1373\/clinchem.2019.306837","article-title":"Multicenter evaluation of circulating cell-free DNA extraction and downstream analyses for the development of standardized (Pre)analytical work flows","volume":"66","author":"Lampignano","year":"2020","journal-title":"Clin. Chem."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105223_bib44","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1021\/acs.analchem.4c06592","article-title":"Small extracellular vesicles detection by dielectrophoresis-based microfluidic chip filled with transparent antibody-conjugated microbeads for breast cancer diagnosis","volume":"97","author":"Lan","year":"2025","journal-title":"Anal. Chem."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105223_bib45","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13058-023-01616-5","article-title":"Diagnostic accuracy of a three-protein signature in women with suspicious breast lesions: a multicenter prospective trial","volume":"25","author":"Lee","year":"2023","journal-title":"Breast Cancer Res"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105223_bib46","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/s12967-024-05039-4","article-title":"Development and validation of a model and nomogram for breast cancer diagnosis based on quantitative analysis of serum disease-specific haptoglobin N-glycosylation","volume":"22","author":"Li","year":"2024","journal-title":"J. Transl. Med"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105223_bib47","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10549-018-4757-3","article-title":"Circulating microRNAs from the miR-106a\u2013363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer","volume":"170","author":"Li","year":"2018","journal-title":"Breast Cancer Res Treat."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105223_bib48","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.sjbs.2018.11.002","article-title":"The diagnostic value of combined detection of genetic markers and serum protein markers on breast cancer","volume":"26","author":"Li","year":"2019","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.critrevonc.2026.105223_bib49","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jare.2024.08.026","article-title":"Simultaneous detection of membrane protein and mRNA at single extracellular vesicle level by droplet microfluidics for cancer diagnosis","volume":"73","author":"Lin","year":"2025","journal-title":"J. Adv. Res"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105223_bib50","article-title":"Cell-free DNA fragmentomics assay to discriminate the malignancy of breast nodules and evaluate treatment response","volume":"23","author":"Liu","year":"2025","journal-title":"Genom. Proteom. Bioinforma."},{"issue":"16","key":"10.1016\/j.critrevonc.2026.105223_bib51","doi-asserted-by":"crossref","first-page":"26625","DOI":"10.18632\/oncotarget.15775","article-title":"Value of circulating cell-free DNA analysis as a diagnostic tool for breast cancer: a meta-analysis","volume":"8","author":"Lin","year":"2017","journal-title":"Oncotarget"},{"issue":"15","key":"10.1016\/j.critrevonc.2026.105223_bib52","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.2217\/bmm-2022-0290","article-title":"Serum Cyr61 As A Potential Biomarker to Improve Breast Cancer Diagnostics","volume":"16","author":"Lin","year":"2022","journal-title":"Biomark. Med"},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105223_bib53","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.1111\/cas.15935","article-title":"Discovery of lipid profiles in plasma-derived extracellular vesicles as biomarkers for breast cancer diagnosis","volume":"114","author":"Liu","year":"2023","journal-title":"Cancer Sci."},{"key":"10.1016\/j.critrevonc.2026.105223_bib54","article-title":"Exosomal hsa-miR-21-5p is a biomarker for breast cancer diagnosis","volume":"9","author":"Liu","year":"2021","journal-title":"PeerJ"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105223_bib55","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.annonc.2020.02.011","article-title":"Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA","volume":"31","author":"Liu","year":"2020","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105223_bib56","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10147-016-1047-0","article-title":"A panel of autoantibodies as potential early diagnostic serum biomarkers in patients with breast cancer","volume":"22","author":"Liu","year":"2017","journal-title":"Int J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105223_bib57","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.3390\/cancers11121872","article-title":"A circulating miRNA signature for stratification of breast lesions among women with abnormal screening mammograms","volume":"11","author":"Loke","year":"2019","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105223_bib58","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3390\/medicina60010168","article-title":"Exploring biomarkers in breast cancer: hallmarks of diagnosis, treatment, and follow-up in clinical practice","volume":"60","author":"Lopez-Gonzalez","year":"2024","journal-title":"Medicina"},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105223_bib59","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.clbc.2017.05.004","article-title":"A noninvasive blood-based combinatorial proteomic biomarker assay to detect breast cancer in women under the age of 50 years","volume":"17","author":"Lourenco","year":"2017","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.critrevonc.2026.105223_bib60","article-title":"Liquid biopsy epigenetics: establishing a molecular profile based on cell-free DNA","author":"Maansson","year":"2025","journal-title":"Mol. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105223_bib61","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41523-021-00239-3","article-title":"Circulating tumor DNA and magnetic resonance imaging to predict neoadjuvant chemotherapy response and recurrence risk","volume":"7","author":"Magbanua","year":"2021","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.critrevonc.2026.105223_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlb.2025.100299","article-title":"The impact of liquid biopsy in breast cancer: redefining the landscape of non-invasive precision oncology","volume":"8","author":"Malik","year":"2025","journal-title":"J. Liq. Biopsy"},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105223_bib63","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1158\/1078-0432.CCR-11-2527","article-title":"Serum autoantibody signature of ductal carcinoma in situ progression to invasive breast cancer","volume":"18","author":"Mang\u00e9","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105223_bib64","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1007\/s00330-022-08617-6","article-title":"Breast cancer screening in women with extremely dense breasts recommendations of the European Society of Breast Imaging (EUSOBI)","volume":"32","author":"Mann","year":"2022","journal-title":"Eur. Radio."},{"key":"10.1016\/j.critrevonc.2026.105223_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2024.1337706","article-title":"MicroRNA as a promising molecular biomarker in the diagnosis of breast cancer","volume":"11","author":"Miranda","year":"2024","journal-title":"Front Mol. Biosci."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105223_bib66","doi-asserted-by":"crossref","first-page":"9347","DOI":"10.1038\/s41598-024-59863-1","article-title":"Spectroscopic insight into breast cancer: profiling small extracellular vesicles lipids via infrared spectroscopy for diagnostic precision","volume":"14","author":"Mishra","year":"2024","journal-title":"Sci. Rep."},{"issue":"30","key":"10.1016\/j.critrevonc.2026.105223_bib67","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating microRNAs as stable blood-based markers for cancer detection","volume":"105","author":"Mitchell","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.critrevonc.2026.105223_bib68","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.3332\/ecancer.2020.1146","article-title":"A review of barriers and facilitators to mammography in Asian women","volume":"14","author":"Momenimovahed","year":"2020","journal-title":"Ecancermedicalscience"},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105223_bib69","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1158\/1078-0432.CCR-15-0654","article-title":"Identification of developmental endothelial locus-1 on circulating extracellular vesicles as a novel biomarker for early breast cancer detection","volume":"22","author":"Moon","year":"2016","journal-title":"Clin. Cancer Res"},{"issue":"22","key":"10.1016\/j.critrevonc.2026.105223_bib70","doi-asserted-by":"crossref","first-page":"6694","DOI":"10.3390\/jcm11226694","article-title":"Plasma Levels of CXC Motif Chemokine 1 (CXCL1) and Chemokine 8 (CXCL8) as Diagnostic Biomarkers in Luminal A and B Breast Cancer","volume":"11","author":"Motyka","year":"2022","journal-title":"J. Clin. Med"},{"issue":"18","key":"10.1016\/j.critrevonc.2026.105223_bib71","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1021\/acs.jpcb.5c00290","article-title":"A new strategy to modify glass for capture and detection of small extracellular vesicles","volume":"129","author":"Ngo","year":"2025","journal-title":"J. Phys. Chem. B"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105223_bib72","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12916-025-03929-y","article-title":"Prospective validation study: a non-invasive circulating tumor DNA-based assay for simultaneous early detection of multiple cancers in asymptomatic adults","volume":"23","author":"Nguyen","year":"2025","journal-title":"BMC Med"},{"issue":"22","key":"10.1016\/j.critrevonc.2026.105223_bib73","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1001\/jama.2024.5534","article-title":"Screening for breast cancer: US preventive services task force recommendation statement","volume":"331","author":"Nicholson","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.critrevonc.2026.105223_bib74","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/1471-2407-11-381","article-title":"Searching for early breast cancer biomarkers by serum protein profiling of pre-diagnostic serum; a nested case-control study","volume":"11","author":"Opstal-van Winden","year":"2011","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105223_bib75","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3390\/biom10010150","article-title":"Identification of miRNAs enriched in extracellular vesicles derived from serum samples of breast cancer patients","volume":"10","author":"Ozawa","year":"2020","journal-title":"Biomolecules"},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105223_bib76","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.3390\/ijms21082783","article-title":"A tetra-panel of serum circulating miRNAs for the diagnosis of the four most prevalent tumor types","volume":"21","author":"Pastor-Navarro","year":"2020","journal-title":"Int J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105223_bib77","doi-asserted-by":"crossref","first-page":"8793","DOI":"10.3390\/curroncol30100634","article-title":"Autoantibody Diversity Is Augmented in Women with Breast Cancer and Is Related to the Stage of the Disease","volume":"30","author":"P\u00e9rez-Hern\u00e1ndez","year":"2023","journal-title":"Curr. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105223_bib78","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s12032-020-01353-1","article-title":"Will traditional biopsy be substituted by radiomics and liquid biopsy for breast cancer diagnosis and characterisation?","volume":"37","author":"Pesapane","year":"2020","journal-title":"Med Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105223_bib79","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrg3198","article-title":"MicroRNA profiling: approaches and considerations","volume":"13","author":"Pritchard","year":"2012","journal-title":"Nat. Rev. Genet"},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105223_bib80","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/1354750X.2024.2406520","article-title":"Serum exosomal miR-200c is a potential diagnostic biomarker for breast cancer","volume":"29","author":"Qiao","year":"2024","journal-title":"Biomarkers"},{"key":"10.1016\/j.critrevonc.2026.105223_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1288077","article-title":"Circulating tumor biomarkers in early-stage breast cancer: characteristics, detection, and clinical developments","volume":"13","author":"Qiu","year":"2023","journal-title":"Front Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105223_bib82","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41598-021-04176-w","article-title":"Identification and validation of plasma biomarkers for diagnosis of breast cancer in South Asian women","volume":"12","author":"Rajkumar","year":"2022","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105223_bib83","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1080\/09674845.2020.1784568","article-title":"A novel serum metabolome score for breast cancer diagnosis","volume":"77","author":"Rashed","year":"2020","journal-title":"Br. J. Biomed. Sci."},{"issue":"30","key":"10.1016\/j.critrevonc.2026.105223_bib84","doi-asserted-by":"crossref","first-page":"49915","DOI":"10.18632\/oncotarget.18307","article-title":"Does the 1H NMR plasma metabolome reflect the host-tumor interactions in human breast cancer?","volume":"8","author":"Richard","year":"2017","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105223_bib85","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1158\/1055-9965.EPI-20-0331","article-title":"Autoantibodies in early detection of breast cancer","volume":"29","author":"Rauf","year":"2020","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.critrevonc.2026.105223_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlb.2025.100312","article-title":"Liquid biopsy in breast cancer: redefining precision medicine","volume":"9","author":"Schiavone","year":"2025","journal-title":"J. Liq. Biopsy"},{"issue":"10409","key":"10.1016\/j.critrevonc.2026.105223_bib87","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/S0140-6736(23)01700-2","article-title":"Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort study","volume":"402","author":"Schrag","year":"2023","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105223_bib88","doi-asserted-by":"crossref","first-page":"46","DOI":"10.7326\/M19-2125","article-title":"Breast cancer screening and diagnosis: a synopsis of the European breast guidelines","volume":"172","author":"Sch\u00fcnemann","year":"2020","journal-title":"Ann. Intern Med"},{"key":"10.1016\/j.critrevonc.2026.105223_bib89","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.1075810","article-title":"Screening and diagnosis of triple negative breast cancer based on rapid metabolic fingerprinting by conductive polymer spray ionization mass spectrometry and machine learning","volume":"10","author":"Song","year":"2022","journal-title":"Front Cell Dev. Biol."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105223_bib90","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1158\/1078-0432.CCR-08-1059","article-title":"Clinical applications of metabolomics in oncology: a review","volume":"15","author":"Spratlin","year":"2009","journal-title":"Clin. Cancer Res"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105223_bib91","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13058-025-02029-2","article-title":"miRNA panel from HER2+ and CD24+ plasma extracellular vesicle subpopulations as biomarkers of early-stage breast cancer","volume":"27","author":"Spychalski","year":"2025","journal-title":"Breast Cancer Res"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105223_bib92","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1158\/1078-0432.CCR-04-0538","article-title":"T cell\u2013dependent antibody responses against aberrantly expressed cyclin B1 protein in patients with cancer and premalignant disease","volume":"11","author":"Suzuki","year":"2005","journal-title":"Clin. Cancer Res"},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105223_bib93","doi-asserted-by":"crossref","first-page":"12321","DOI":"10.1002\/jcb.28496","article-title":"Clinical significance of blood-based miRNAs as diagnostic and prognostic nucleic acid markers in breast cancer: comparative to conventional tumor markers","volume":"120","author":"Swellam","year":"2019","journal-title":"J. Cell Biochem"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105223_bib94","doi-asserted-by":"crossref","first-page":"S242","DOI":"10.1016\/j.annonc.2024.08.078","article-title":"70MO Cell-free DNA indicates potential preclinical detectability of cancer signals up to 30 months prior to diagnosis","volume":"35","author":"Vachon","year":"2024","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105223_bib95","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s12915-025-02371-z","article-title":"Multimodal analysis of cell-free DNA enhances differentiation of early-stage breast cancer from benign lesions and healthy individuals","volume":"23","author":"Van","year":"2025","journal-title":"BMC Biol."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105223_bib96","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1021\/pr100395s","article-title":"Serum Degradome Markers for the Detection of Breast Cancer","volume":"9","author":"van Winden","year":"2010","journal-title":"J. Proteome Res"},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105223_bib97","article-title":"Robust sequential biophysical fractionation of blood plasma to study variations in the biomolecular landscape of systemically circulating extracellular vesicles across clinical conditions","volume":"10","author":"Vergauwen","year":"2021","journal-title":"J. Extra Vesicles"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105223_bib98","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13072-023-00508-4","article-title":"Altered cfDNA fragmentation profile in hypomethylated regions as diagnostic markers in breast cancer","volume":"16","author":"Wang","year":"2023","journal-title":"Epigenetics Chromatin"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105223_bib99","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3233\/CBM-181500","article-title":"Taurine, glutamic acid and ethylmalonic acid as important metabolites for detecting human breast cancer based on the targeted metabolomics","volume":"23","author":"Wang","year":"2018","journal-title":"Cancer Biomark."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105223_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110345","article-title":"Largescale multicenter study of a serum metabolite biomarker panel for the diagnosis of breast cancer","volume":"27","author":"Wang","year":"2024","journal-title":"iScience"},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105223_bib101","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.480","article-title":"Serum semaphorin4C as an auxiliary diagnostic biomarker for breast cancer","volume":"11","author":"Wang","year":"2021","journal-title":"Clin. Transl. Med"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105223_bib102","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J. Extra Vesicles"},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105223_bib103","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.tifs.2008.03.003","article-title":"Metabolomics: applications to food science and nutrition research","volume":"19","author":"Wishart","year":"2008","journal-title":"Trends Food Sci. Technol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105223_bib104","doi-asserted-by":"crossref","first-page":"24559","DOI":"10.1038\/s41598-024-73097-1","article-title":"Serum metabolite and metal ions profiles for breast cancer screening","volume":"14","author":"Wojtowicz","year":"2024","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105223_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.109506","article-title":"Tumor-derived extracellular vesicles as a biomarker for breast cancer diagnosis and metastasis monitoring","volume":"27","author":"Xu","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.critrevonc.2026.105223_bib106","article-title":"Circulating tumor DNA: from discovery to clinical application in breast cancer","volume":"15","author":"Xu","year":"2024","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105223_bib107","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1021\/acsnano.4c13557","article-title":"Concurrent detection of protein and miRNA at the single extracellular vesicle level using a digital dual CRISPR-cas assay","volume":"19","author":"Xu","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.critrevonc.2026.105223_bib108","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1035402","article-title":"Autoantibodies as biomarkers for breast cancer diagnosis and prognosis","volume":"13","author":"Yang","year":"2022","journal-title":"Front Immunol."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105223_bib109","doi-asserted-by":"crossref","first-page":"491","DOI":"10.14740\/jocmr5237","article-title":"The effects of preoperative serum carcinoembryonic antigen, cancer antigen 15-3 and cancer antigen 125 on the prognosis of breast cancer patients with different molecular subtypes","volume":"16","author":"Yilihamu","year":"2024","journal-title":"J. Clin. Med Res"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105223_bib110","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s12253-018-0527-0","article-title":"Human plasma levels of VEGF-A, VEGF-C, VEGF-D, their soluble receptor - VEGFR-2 and applicability of these parameters as tumor markers in the diagnostics of breast cancer","volume":"25","author":"Zajkowska","year":"2019","journal-title":"Pathol. Oncol. Res"},{"issue":"46","key":"10.1016\/j.critrevonc.2026.105223_bib111","doi-asserted-by":"crossref","first-page":"39478","DOI":"10.1021\/acsami.8b12725","article-title":"In situ detection of plasma exosomal MicroRNA-1246 for breast cancer diagnostics by a Au nanoflare probe","volume":"10","author":"Zhai","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.critrevonc.2026.105223_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2021.339382","article-title":"A universal catalytic hairpin assembly system for direct plasma biopsy of exosomal PIWI-interacting RNAs and microRNAs","volume":"1192","author":"Zhang","year":"2022","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.critrevonc.2026.105223_bib113","doi-asserted-by":"crossref","DOI":"10.1177\/15330338211033061","article-title":"The potential diagnostic accuracy of Let-7 family for cancer: a meta-analysis","volume":"20","author":"Zhang","year":"2021","journal-title":"Technol. Cancer Res Treat."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105223_bib114","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.71004","article-title":"An approach for differential diagnosis of breast tumors by ctDNA methylation sequencing","volume":"14","author":"Zhang","year":"2025","journal-title":"Cancer Med"},{"issue":"24","key":"10.1016\/j.critrevonc.2026.105223_bib115","doi-asserted-by":"crossref","first-page":"9858","DOI":"10.1021\/ac902437g","article-title":"Rapid and label-free detection of breast cancer biomarker CA15-3 in clinical human serum samples with optofluidic ring resonator sensors","volume":"81","author":"Zhu","year":"2009","journal-title":"Anal. Chem."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105223_bib116","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3233\/CBM-201547","article-title":"MicroRNA profiling in serum: Potential signatures for breast cancer diagnosis","volume":"30","author":"Zou","year":"2021","journal-title":"Cancer Biomark."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826001101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826001101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T11:56:29Z","timestamp":1775908589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826001101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":116,"alternative-id":["S1040842826001101"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105223","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood-based biomarkers for breast cancer screening and early diagnosis: Diagnostic performance and challenges for clinical implementation","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105223","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105223"}}